Clinical trial · Interventional
Carcinologic Speech Severity Index
A Speech Disorders Severity Index to Measure the Impact of Oral and Pharyngeal Cavity on Speech Production
NCT02875795CI-TRIAL-00046253C2SIcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The hypothesis of the present study is that an automatic assessment technic can measure the impact of the speech disorders on the communication abilities giving a severity index of speech in patients treated for head and neck and particularly for oral and pharyngeal cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| automatic speech processing tool | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- speech intelligibility
- description
- speech intelligibility is registered by an automatic speech processing tool
- interventionNames
- Procedure: automatic speech processing tool
Primary outcomes (1)
- measure
- carcinologic speech severity index
- timeFrame
- day 0
- description
- The main objective is to demonstrate that the carcinologic speech severity index (C2SI), obtained by an automatic speech processing tool, produces equivalent or superior outcomes than a score of speech intelligibility obtained by human listeners, in terms of quality of life foreseeing the speech handicap, after the treatment of oral and/or pharyngeal cancer.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Oral and Pharyngeal cancer T2 to T4 for having a wide dynamic of deficit * Treatment by surgery and/or radiotherapy and/or chemotherapy * Delay after the end of the treatment of minimum 6 months. Exclusion Criteria: * Patients with a previous speech disorders (ie stuttering… ) * Patients not able to perform the whole task
References
Publications (1)
- RESULTBalaguer M, Boisguerin A, Galtier A, Gaillard N, Puech M, Woisard V. Assessment of impairment of intelligibility and of speech signal after oral cavity and oropharynx cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Oct;136(5):355-359. doi: 10.1016/j.anorl.2019.05.012. Epub 2019 Jun 6. PMID 31178430